Ilex Medical Statistics
Ilex Medical (ILX) Stock Statistics & Valuation Metrics
Total Valuation
Ilex Medical has a market cap or net worth of ILA 526.29M. The enterprise value is ILA 405.53T.
- Market Cap
- ILA 526.29M
- Enterprise Value
- ILA 405.53T
Share Statistics
Ilex Medical has 11,188,107 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,188,107
- Owned by Insiders
- ―
- Owned by Institutions
- 0.31%
Financial Efficiency
Ilex Medical’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.58%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 5.58%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 5.14M
- Profits Per Employee
- 306.93K
- Employee Count
- 181
- Asset Turnover
- 0.94
- Inventory Turnover
- 3.70
Valuation Ratios
The current PE Ratio of Ilex Medical is 13.57. Ilex Medical’s PEG ratio is -0.92.
- PE Ratio
- 13.57
- PS Ratio
- 0.60
- PB Ratio
- 0.79
- Price to FCF
- 11.41
- Price to Operating Cash Flow
- 6.14
- PEG Ratio
- -0.92
Income Statement
In the last 12 months, Ilex Medical had revenue of 930.83M and earned 55.55M in profits. Earnings per share was 4.95.
- Revenue
- 930.83M
- Gross Profit
- 211.88M
- Operating Income
- 55.95M
- Pretax Income
- 74.14M
- Net Income
- 55.55M
- EBITDA
- 125.83M
- Earnings Per Share (EPS)
- 4.95
Cash Flow
In the last 12 months, operating cash flow was 85.86M and capital expenditures -39.68M, giving a free cash flow of 46.17M billion.
- Operating Cash Flow
- 85.86M
- Free Cash Flow
- 46.17M
- Free Cash Flow per Share
- 4.13
Dividends & Yields
Ilex Medical pays an annual dividend of ILA 198.62, resulting in a dividend yield of 4.22%
- Dividend Per Share
- ILA 198.62
- Dividend Yield
- 4.22%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.76%
- Earnings Yield
- 7.38%
Stock Price Statistics
- Beta
- 0.27
- 52-Week Price Change
- -26.59%
- 50-Day Moving Average
- 4859.42
- 200-Day Moving Average
- 5279.83
- Relative Strength Index (RSI)
- 51.01
- Average Volume (3m)
- 1,815
Important Dates
Ilex Medical upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- ―
- Next Earnings Date
- ―
- Ex-Dividend Date
- Apr 10, 2026
Financial Position
Ilex Medical as a current ratio of 2.83, with Debt / Equity ratio of 6.81%
- Current Ratio
- 2.83
- Quick Ratio
- 2.07
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.03
- Interest Coverage Ratio
- 25.49
Taxes
In the past 12 months, Ilex Medical has paid 18.58M in taxes.
- Income Tax
- 18.58M
- Effective Tax Rate
- 0.25
Enterprise Valuation
Ilex Medical EV to EBITDA ratio is 4.05, with an EV/FCF ratio of 8.50.
- EV to Sales
- 0.44
- EV to EBITDA
- 4.05
- EV to Free Cash Flow
- 8.50
- EV to Operating Cash Flow
- 4.57
Balance Sheet
Ilex Medical has ILA 217.05M in cash and marketable securities with ILA 49.04M in debt, giving a net cash position of ILA 168.00M billion.
- Cash & Marketable Securities
- ILA 217.05M
- Total Debt
- ILA 49.04M
- Net Cash
- ILA 168.00M
- Net Cash Per Share
- ILA 15.02
- Tangible Book Value Per Share
- ILA 58.39
Margins
Gross margin is 22.32%, with operating margin of 4.73%, and net profit margin of 4.39%.
- Gross Margin
- 22.32%
- Operating Margin
- 4.73%
- Pretax Margin
- 6.04%
- Net Profit Margin
- 4.39%
- EBITDA Margin
- 10.93%
- EBIT Margin
- 5.42%
Analyst Forecast
The average price target for Ilex Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -4.76%
- EPS Growth Forecast
- -14.70%
